Biotech

Biochip technology in GWC Technologies Inc.'s SpotReady product line has been patented, the company said. GWC licenses the technology exclusively from the Wisconsin Alumni Research Foundation. GWC says its approach makes it easier for researchers to prepare biochips full of proteins or other molecules without...

Madison's Third Wave Technologies saw its stock price rise 25 percent the day following its announcement of a successful trial phase for its human papillomavirus (HPV) test. ...

Madison is expected to be the destination of prominent stem cell researchers this fall when it hosts the World Stem Cell Summit. The event, to be held Sept. 22 and 23, will be hosted by the WiCell Research Institute and the University of Wisconsin-Madison's Stem...

DNASTAR, a Madison-based developer of bioinformatics software, has gained a foothold in the Chinese biotechnology market with the signing of a distribution agreement with BGI LifeTech, a molecular biology products distributor based in Beijing. ...

Final decisions on two stem cell patents by the U.S. Patent and Trademark Office reinforce the patentability of University of Wisconsin-Madison professor Jamie Thomson's human embryonic stem cell discoveries. The patent office rulings mark the second time in two weeks that a patent examiner has...

Midwestern life science companies struggle to raise venture capital at the early stages, but one state stands out in developing creative solutions to the problem, according to Yer Biotech Blues columnist Michael Rosen. Citing Act 255 and new proposals to boost angel and venture capital...

Third Wave Technologies has achieved its primary goals in clinical trials for its tests for the human papillomavirus (HPV), which has been linked to cervical cancer in women. The company will submit trial results for HPV high-risk, 16/18 genotyping products to the FDA in April. ...